We are heartbroken to announce that Professor Stephen “Ben” Benedict Walsh, died peacefully on 30th September 2024 while surrounded by family & friends.

Ben's passion for science & medicine was an integral part of who he was. And after self-diagnosing with lung cancer back in early March of 2023, he decided to keep his condition private to protect his clinical and academic work, only disclosing his diagnosis publicly in early September of 2024 as he entered palliative care.  Remarkably Ben continued to work throughout his illness, right to the very end, ensuring that his students, colleagues and patients were taken care of, and that all he had built at the London Tubular Centre would continue on.

There are no words to really express the profound sorrow we feel, the depth of loss we feel for a dear friend, colleague and mentor. He will leave a very large hole in our lives and he will not be forgotten. He is survived by his partner Chiara, their son Silas, his mother Mary and sister Kate.

For those who wish to pay their respects, there is link to the video livestream for Ben's Memorial Celebration taking place at 11am [BST], Tuesday 22nd October:
https://tinyurl.com/ytwe385z

Please leave messages of condolences on EverLoved:
https://everloved.com/life-of/stephen-walsh/

We are also fundraising for an annual memorial tribute to honour Ben and his academic and clinical achievements on JustGiving:
https://www.justgiving.com/page/in-memory-of-prof-ben-walsh

We're also requesting anyone with pictures, videos, new articles, etc… of Ben to upload these to Dropbox:
https://dropbox.com/request/6tiIZ7QFEb8l8IFArsps

We are a multi-disciplinary laboratory group of clinicians, scientists and engineers based at the UCL Department of Renal Medicine.

We study rare kidney diseases utilising molecular biology, electrophysiology, 3D cell culture, advanced 3D imaging, proteomics, spatial transcriptomics and experimental medicine. We focus on human research, using human cells and tissue wherever possible.

In addition to discovery science, we aim to translate our techniques back to clinical care.

News

Twitter Feed

Funding bodies